New treatment tested for painful skin condition in china
NCT ID NCT07489573
Summary
This study is testing a medication called secukinumab to see how well it works and how safe it is for Chinese adults with moderate-to-severe hidradenitis suppurativa (HS), a painful skin condition. It will follow 36 participants for about one year, comparing two different dosing schedules. The main goal is to see if the treatment reduces painful skin lesions by at least 50% and improves patients' pain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.